Recombinant Human Thymosin β4

DRUG2 trials

Sponsors

Beijing Northland Biotech. Co., Ltd.

Conditions

Healthy

Phase 1

A Phase 1a Study of Thymosin Beta 4 in Healthy Volunteers

CompletedNCT04555824

Beijing Northland Biotech. Co., Ltd.Healthy

Start: 2017-07-17End: 2018-06-20Updated: 2020-09-29

A Phase 1b Study of Thymosin Beta 4 in Healthy Volunteers

CompletedNCT04555850

Beijing Northland Biotech. Co., Ltd.Healthy

Start: 2018-07-30End: 2019-07-26Updated: 2020-09-29